Selexys Pharmaceuticals Corporation

About:

Selexys Pharmaceuticals is a company focused on developing drugs to treat inflammatory and thrombotic diseases.

Website: http://www.selexys.com

Top Investors: MPM Capital, i2E, Oklahoma Seed Capital Fund

Description:

Selexys Pharmaceuticals Corporation (Selexys) is a privately held company that is developing drugs to treat inflammatory and thrombotic diseases. They are targeting the underlying disease mechanism for these disorders. Their target is the adhesion of white blood cells to sites of inflammation mediated by the binding of two proteins, P-selectin and PSGL-1. The company is in preclinical development of humanized antibodies to P-selectin and PSGL-1 for the treatment of acute and chronic inflammatory and thrombotic disorders. Unregulated inflammatory processes play a major role in the harmful effects of multiple inflammatory disorders.